Clovis Oncology to Highlight Rubraca® (rucaparib) Data from Post-Hoc ARIEL3 Analyses at SGO 2019 Congress

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that data from post hoc exploratory analyses …

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that data from post hoc exploratory analyses ...